Table of Contents Author Guidelines Submit a Manuscript
International Journal of Electrochemistry
Volume 2012 (2012), Article ID 183745, 10 pages
http://dx.doi.org/10.1155/2012/183745
Research Article

Interaction of Calf Thymus DNA with the Ni(II) Complex of Sodium 1,4-Dihydroxy-9,10-Anthraquinone-2-Sulphonate: A Novel Method of Analysis Using Cyclic Voltammetry

1Chemical Sciences Division, Saha Institute of Nuclear Physics, 1/AF-Bidhannagar, Kolkata 700064, India
2Department of Chemistry, Jadavpur University, Raja S. C. Mullick Road, Kolkata 700032, India
3Department of Chemistry, Shibpur Dinobundhoo Institution (College), 412/1 G. T. Road (South), Howrah 711102, India

Received 15 February 2011; Accepted 20 April 2011

Academic Editor: Rene Kizek

Copyright © 2012 Partha Sarathi Guin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. G. Hardman, A. G. Gilman, and L. E. Limbird, Goodman and Gilman’s The Pharmacological Basis of Therapeutics, McGraw-Hill Companies, New York, NY, USA, 9th edition, 1996.
  2. K. Reszka, P. Kolodziejczyk, J. A. Hartley, W. D. Wilson, and J. W. Lown, Anthracycline and Anthracenedionebased Anticancer Agents, Elsevier Press, Amsterdam, Netherlands, 1998.
  3. V. J. Ferrans, “Overview of cardiac pathology in relation to anthracycline cardiotoxocity,” Cancer Treatment Reports, vol. 62, no. 6, pp. 955–961, 1978. View at Google Scholar · View at Scopus
  4. D. Barasch, O. Zipori, I. Ringel, I. Ginsburg, A. Samuni, and J. Katzhendler, “Novel anthraquinone derivatives with redox-active functional groups capable of producing free radicals by metabolism: are free radicals essential for cytotoxicity?” European Journal of Medicinal Chemistry, vol. 34, no. 7-8, pp. 597–615, 1999. View at Google Scholar · View at Scopus
  5. K. E. Coldwell, S. M. Cutts, T. J. Ognibene, P. T. Henderson, and D. R. Phillips, “Detection of Adriamycin-DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations,” Nucleic Acids Research, vol. 36, no. 16, article e100, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. D. A. Gewirtz, “A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin,” Biochemical Pharmacology, vol. 57, no. 7, pp. 727–741, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. K. M. Tewey, T. C. Rowe, L. Yang, B. D. Halligan, and L. F. Liu, “Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II,” Science, vol. 226, no. 4673, pp. 466–468, 1984. View at Google Scholar · View at Scopus
  8. M. Gigli, S. M. Doglia, J. M. Millot, L. Valentini, and M. Manfait, “Quantitative study of doxorubicin in living cell nuclei by microspectrofluorometry,” Biochimica et Biophysica Acta, vol. 950, no. 1, pp. 13–20, 1988. View at Google Scholar · View at Scopus
  9. J. Cummings and C. S. McArdle, “Studies on the in vivo disposition of adriamycin in human tumours which exhibit different responses to the drug,” British Journal of Cancer, vol. 53, no. 6, pp. 835–838, 1986. View at Google Scholar · View at Scopus
  10. T. Terasaki, T. Iga, Y. Sugiyama, Y. Sawada, and M. Hanano, “Nuclear binding as a determinant of tissue distribution of adriamycin, daunomycin, adriamycinol, daunorubicinol and actinomycin D,” Journal of Pharmacobiodyn, vol. 7, no. 5, pp. 269–277, 1984. View at Google Scholar
  11. H. Fialkoff, M. F. Goodman, and M. W. Seraydarian, “Differential effect of adriamycin on DNA replicative and repair synthesis in cultured neonatal rat cardiac cells,” Cancer Research, vol. 39, no. 4, pp. 1321–1327, 1979. View at Google Scholar · View at Scopus
  12. D. C. Ward, E. Reich, and I. H. Goldberg, “Base specificity in the interaction of polynucleotides with antibiotic drugs,” Science, vol. 149, no. 3689, pp. 1259–1263, 1965. View at Google Scholar · View at Scopus
  13. E. Calendi, A. DiMarco, M. Reggiani, B. Scarpinate, and L. Valentini, “On physico-chemical interactions between daunomycin and nucleic acids,” Biochimica et Biophysica Acta, vol. 103, pp. 25–49, 1965. View at Google Scholar
  14. W. J. Pigram, W. Fuller, and L. D. Hamilton, “Stereochemistry of intercalation: interaction of daunomycin with DNA,” Nature: New biology, vol. 235, no. 53, pp. 17–19, 1972. View at Google Scholar · View at Scopus
  15. Y. Kawakami and A. J. Hopfinger, “Prediction of initial reduction potentials of compounds related to anthracyclines and implications for estimating cardiotoxicity,” Chemical Research in Toxicology, vol. 3, no. 3, pp. 244–247, 1990. View at Google Scholar · View at Scopus
  16. F. C. de Abreu, P. A. L. de Ferraz, and M. O. F. Goulart, “Some applications of electrochemistry in biomedical chemistry. Emphasis on the correlation of electrochemical and bioactive properties,” Journal of the Brazilian Chemical Society, vol. 13, no. 1, pp. 19–35, 2002. View at Google Scholar · View at Scopus
  17. J. W. Lown, H. H. Chen, and J. A. Plambeck, “Further studies on the generation of reactive oxygen species from activated anthracyclines and the relationship to cytotoxic action and cardiotoxic effects,” Biochemical Pharmacology, vol. 31, no. 4, pp. 575–581, 1982. View at Publisher · View at Google Scholar · View at Scopus
  18. R. L. Blankespoor, E. L. Kosters, A. J. Post, and D. P. VanMeurs, “Substituent effects upon the peak potentials and reductive cleavage rate constants of hydroxy- and methoxy-substituted 9,10-anthraquinones in 50% aqueous CHCN: do they correlate?” Journal of Organic Chemistry, vol. 56, no. 4, pp. 1609–1614, 1991. View at Google Scholar · View at Scopus
  19. A. Kumbhar, S. Padhye, and D. Ross, “Cytotoxic properties of iron-hydroxynaphthoquinone complexes in rat hepatocytes,” BioMetals, vol. 9, no. 3, pp. 235–240, 1996. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Bartoszek, “Metabolic activation of adriamycin by NADPH-cytochrome P450 reductase; overview of its biological and biochemical effects,” Acta Biochimica Polonica, vol. 49, no. 2, pp. 323–331, 2002. View at Google Scholar · View at Scopus
  21. S. Das, A. Saha, and P. C. Mandal, “Radiosensitization of uracil by Cu(II) and Ni(II) complexes of 1,2 dihydroxy 9,10 anthraquinone,” Journal of Radioanalytical and Nuclear Chemistry, vol. 196, pp. 57–63, 1996. View at Google Scholar
  22. S. Das, A. Saha, and P. C. Mandal, “Radiation-induced double-strand modification in calf thymus DNA in the presence of 1,2-dihydroxy-9,10-anthraquinone and its Cu(II) complex,” Environmental Health Perspectives, vol. 105, no. 6, pp. 1459–1462, 1997. View at Google Scholar · View at Scopus
  23. S. Das and P. C. Mandal, “Influence of Ni(II) and Fe(III) complexes of 1,2 dihydroxy 9,10 anthraquinone on the modification in calf thymus DNA upon gamma irradiation,” Radiation Physics and Chemistry, vol. 78, no. 1, pp. 37–41, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. J. A. Plambeck and J. W. Lown, “Electrochemical studies of antitumor antibiotics,” Journal of the Electrochemical Society, vol. 131, no. 11, pp. 2556–2563, 1984. View at Google Scholar · View at Scopus
  25. J. Kapuscinski and Z. Darzynkiewicz, “Relationship between the pharmacological activity of antitumor drugs ametantrone and mitoxantrone (novantrone) and their ability to condense nucleic acids,” Proceedings of the National Academy of Sciences of the United States of America, vol. 83, no. 17, pp. 6302–6306, 1986. View at Google Scholar · View at Scopus
  26. S. Rossi, C. Tabolacci, A. Lentini et al., “Anthraquinones danthron and quinizarin exert antiproliferative and antimetastatic activity on murine B16-F10 melanoma cells,” Anticancer Research, vol. 30, no. 2, pp. 445–449, 2010. View at Google Scholar · View at Scopus
  27. P. Varadwaj, K. Misra, A. Sharma, and R. Kumar, “Mitoxantrone: an agent with promises for anticancer therapies,” Electronic Journal of Biology, vol. 6, pp. 36–42, 2010. View at Google Scholar
  28. C. Menke, T. Goncharov, L. Qamar et al., “TRAIL receptor signaling regulation of chemosensitivity in vivo but not in vitro,” PLoS ONE, vol. 6, pp. 1–8, 2011. View at Google Scholar
  29. H. Beraldo, A. Garnier-Suillerot, L. Tosi, and F. Lavelle, “Iron(III)-adriamycin and iron(III)-daunorubicin complexes: physicochemical characteristics, interaction with DNA, and antitumor activity,” Biochemistry, vol. 24, no. 2, pp. 284–289, 1985. View at Google Scholar · View at Scopus
  30. M. M. L. Fiallo and A. Garnier-Suillerot, “Metal anthracycline complexes as a new class of anthracycline derivatives. Pd(II)-adriamycin and Pd(II)-daunorubicin complexes: physicochemical characteristics and antitumor activity,” Biochemistry, vol. 25, no. 4, pp. 924–930, 1986. View at Google Scholar · View at Scopus
  31. S. Das, A. Saha, and P. C. Mandal, “Studies on the formation of Cu(II) and Ni(II) complexes of 1,2-dihydroxy-9,10-anthraquinone and lack of stimulated superoxide formation by the complexes,” Talanta, vol. 43, no. 1, pp. 95–102, 1996. View at Google Scholar · View at Scopus
  32. P. S. Guin, S. Das, and P. C. Mandal, “Studies on the formation of a complex of Cu(II) with sodium 1,4-dihydroxy-9,10-anthraquinone-2-sulphonate—an analogue of the core unit of anthracycline anticancer drugs and its interaction with calf thymus DNA,” Journal of Inorganic Biochemistry, vol. 103, no. 12, pp. 1702–1710, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. P. S. Guin, S. Das, and P. C. Mandal, “Electrochemical reduction of sodium 1,4-dihydroxy-9,10-anthraquinone-2-sulphonate in aqueous and aqueous dimethyl formamide mixed solvent: a cyclic voltametric study,” International Journal of Electrochemcal Science, vol. 3, pp. 1016–1028, 2008. View at Google Scholar
  34. P. S. Guin, S. Das, and P. C. Mandal, “Sodium 1, 4-dihydroxy-9, 10-anthraquinone- 2-sulphonate interacts with calf thymus DNA in a way that mimics anthracycline antibiotics: an electrochemical and spectroscopic study,” Journal of Physical Organic Chemistry, vol. 23, no. 6, pp. 477–482, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. P. S. Guin, S. Das, and P. C. Mandal, “Electrochemical reduction of quinones in different media: a review,” International Journal of Electrochemcal Science, vol. 2011, pp. 1–22, 2011. View at Google Scholar
  36. P. Das, P. S. Guin, P. C. Mandal, M. Paul, S. Paul, and S. Das, “Cyclic voltammetric studies of 1,2,4-trihydroxy-9,10-anthraquinone, its interaction with calf thymus DNA and anti-leukemic activity on MOLT-4 cell lines: a comparison with anthracycline anticancer drugs,” Journal of Physical Organic Chemistry. In press. View at Publisher · View at Google Scholar
  37. P. S. Guin, S. Das, and P. C. Mandal, “Interaction of 1,4-dihydroxy-9,10-anthraquinone with Calf thymus DNA: a comparison with anthracycline anticancer drugs,” Journal of Solution Chemistry, vol. 40, no. 3, pp. 492–501, 2011. View at Publisher · View at Google Scholar
  38. N. Li, Y. Ma, C. Yang, L. Guo, and X. Yang, “Interaction of anticancer drug mitoxantrone with DNA analyzed by electrochemical and spectroscopic methods,” Biophysical Chemistry, vol. 116, no. 3, pp. 199–205, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. J. R. Lancaster Jr., Ed., Bioinorganic Chemistry of Nickel, Wiley-VCH, New York, NY, USA, 1988.
  40. S. Ciurli and S. Mangani, “Nickel containing enzymes,” in Hand Book of Metallo Proteins, I. Bertini, A. Sigel, and H. Sigel, Eds., chapter 4, Marcel Dekker, New York, NY, USA, 2001. View at Google Scholar
  41. P. J. O'Brien, “Molecular mechanisms of quinone cytotoxicity,” Chemico-Biological Interactions, vol. 80, no. 1, pp. 1–41, 1991. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Nemeikaité-Čéniené, E. Sergediené, H. Nivinskas, and N. Čénas, “Cytotoxicity of natural hydroxyanthraquinones: role of oxidative stress,” Zeitschrift fur Naturforschung—Section C, vol. 57, no. 9-10, pp. 822–827, 2002. View at Google Scholar
  43. P. S. Guin, S. Das, and P. C. Mandal, “Formation and characterization of Ni(II) complex of sodium 1,4-dihydroxy-9,10-anthraquinone-2-sulphonate, an analogue of the core unit of anthracycline antibiotics, by different spectroscopic techniques,” International Journal of Pure and Applied Chemistry, vol. 3, pp. 283–290, 2008. View at Google Scholar
  44. M. D. Vaira, P. Orioli, F. Piccioli, B. Bruni, and L. Messori, “Structure of a terbium(III)-quinizarine complex: the first crystallographic model for metalloanthracyclines,” Inorganic Chemistry, vol. 42, no. 10, pp. 3157–3159, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. W. Lang and R. Zander, “Physiological HEPES buffer proposed as a calibrator for pH measurement in human blood,” Clinical Chemistry and Laboratory Medicine, vol. 37, no. 5, pp. 563–571, 1999. View at Publisher · View at Google Scholar · View at Scopus
  46. T. Mukherjee, E. J. Land, A. J. Swallow, P. M. Guyan, and J. M. Bruce, “Successive addition of electrons to sodium quinizarin-2- and -6-sulphonate in aqueous solution. A pulse and γ-radiolysis study,” Journal of the Chemical Society, Faraday Transactions 1, vol. 84, no. 8, pp. 2855–2873, 1988. View at Publisher · View at Google Scholar · View at Scopus
  47. A. J. Bard and L. R. Faulkner, Electrochemical Methods: Fundamentals and Applications, John Wiley & Sons, Singapore, Asia, 2001.
  48. J. A. Pachter, C. H. Huang, V. H. Du Vernay Jr., A. W. Prestayko, and S. T. Crooke, “Viscometric and fluorometric studies of deoxyribonucleic acid interactions of several new anthracyclines,” Biochemistry, vol. 21, no. 7, pp. 1541–1547, 1982. View at Google Scholar · View at Scopus
  49. A. J. Bard, M. T. Cater, and M. Rodoriguez, “Voltammetric studies of the interaction of metal chelates with DNA. 2. tris-chelated omplexes of cobalt(III) and iron(II) with 1,l0-phenanthroline and 2,2'-bipyridine,” Journal of the American Chemical Society, vol. 111, pp. 8901–8911, 1989. View at Google Scholar
  50. M. J. Waring, “DNA modification and cancer,” Annual Review of Biochemistry, vol. 50, pp. 159–192, 1981. View at Google Scholar · View at Scopus
  51. A. Radi, M. A. El Ries, and S. Kandil, “Electrochemical study of the interaction of levofloxacin with DNA,” Analytica Chimica Acta, vol. 495, no. 1-2, pp. 61–67, 2003. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Roy, R. Banerjee, and M. Sarkar, “Direct binding of Cu(II)-complexes of oxicam NSAIDs with DNA backbone,” Journal of Inorganic Biochemistry, vol. 100, no. 8, pp. 1320–1331, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Chakrabarti, B. Bhattacharyya, and D. Dasgupta, “Interaction of mithramycin and chromomycin A3 with d(TAGCTAGCTA)2: role of sugars in antibiotic-DNA recognition,” Journal of Physical Chemistry B, vol. 106, no. 27, pp. 6947–6953, 2002. View at Publisher · View at Google Scholar · View at Scopus
  54. M. A. Mir, S. Majee, S. Das, and D. Dasgupta, “Association of chromatin with anticancer antibiotics, mithramycin and chromomycin A,” Bioorganic and Medicinal Chemistry, vol. 11, no. 13, pp. 2791–2801, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. T. Deba, D. Choudhury, P. S. Guin, M. B. Sahaa, G. Chakrabartib, and S. Das, “A complex of Co(II) with 2-hydroxyphenyl-azo-2-naphthol (HPAN) is far less cytotoxic than the parent compound on A549-lung carcinoma and peripheral blood mononuclear cells: reasons for reduction in cytotoxicity,” Chemico-Biological Interactions, vol. 189, pp. 206–214, 2011. View at Google Scholar
  56. P. S. Guin, S. Das, and P. C. Mandal, “Formation of a novel complex of Ni(II) with the anticancer drug adriamycin and its interaction with calf thymus DNA: A spectroscopic study comparing it with the Ni(II) complex of sodium 1,4-dihydroxy-9,10-anthraquinone-2-sulphonate,” in Proceedings of the International Conference on Physics Biology Interface (ICPBI '09), p. 92, Kolkata, India, December 2009.